蒋平,关伟,戴楠,等.DNA损伤修复基因以及TS、β-tubulinⅢ在骨肉瘤中的表达及其与临床病理的关系[J].第三军医大学学报,2013,35(01):61. Jiang Ping,Guan Wei,Dai Nan,et al.Expression of DNA damage repair genes, thymidylate synthase and β-tubulin Ⅲ in human osteosarcoma tissues and its relationship with clinical pathology of osteosarcoma[J].J Third Mil Med Univ,2013,35(18):61. [2]温磊,孟刚,李懿,等.人骨肉瘤抗失巢凋亡细胞的生物学特性研究[J].第三军医大学学报,2008,30(10):942. WEN Lei,MENG Gang,LI Yi,et al.Biological characteristics of anoikis-resistant cells from human osteosarcoma cell line hFOB1.19[J].J Third Mil Med Univ,2008,30(18):942. [3]闫德雄,苏踊跃,唐红英,等.整合素β1在人表皮细胞株HaCaT增殖中影响的研究[J].第三军医大学学报,2006,28(08):760. [4]李懿,孟刚,郭乔楠.P53和P63蛋白在人骨肉瘤组织及恶性转化细胞株中的表达变化及意义[J].第三军医大学学报,2006,28(08):763. [5]仲召阳,王东,李增鹏,等.骨肉瘤中APE1的表达及其与血管生成的关系[J].第三军医大学学报,2005,27(10):1045. [6]卫佳,李星星,陈英华,等.β-catenin降低外源性hS100A6对骨肉瘤细胞的抑制作用[J].第三军医大学学报,2010,32(16):1703. Wei Jia,Li Xingxing,Chen Yinghua,et al.β-catenin decreases hS100A6-induced inhibition in osteosarcoma cell lines MG63 and U2OS[J].J Third Mil Med Univ,2010,32(18):1703. [7]何畔,梁珊.RNAi抑制XIAP基因诱导MG63细胞凋亡、化疗增敏及其分子机制[J].第三军医大学学报,2010,32(12):1312. He Pan,Liang Shan.RNAi silencing of XIAP gene induces apoptosis and susceptibility to chemotherapy of osteosarcoma cell line MG63[J].J Third Mil Med Univ,2010,32(18):1312. [8]曾静,温磊,黄玉胜,等.神经营养因子酪氨酸激酶受体B对人永生化成骨细胞hFOB1.19恶性转化细胞体外侵袭力的影响[J].第三军医大学学报,2010,32(09):938. Zeng Jing,Wen Lei,Huang Yusheng,et al.Effect of neurotrophic tyrosine kinase receptor B on in vitro invasiveness of malignant transformed hFOB1.19 cells[J].J Third Mil Med Univ,2010,32(18):938. [9]王元元,杨桂红,杨涛,等.人原代表皮干细胞及其传代细胞生物学特性的比较[J].第三军医大学学报,2011,33(01):24. Wang Yuanyuan,Yang Guihong,Yang Tao,et al.Comparative study on biological characteristics between human primary epidermal stem cells and their subcultured cells[J].J Third Mil Med Univ,2011,33(18):24. [10]洪思琦,毕杨,郭振华,等.携带siANGPTL4重组腺病毒的构建及其对MG63增殖的抑制作用[J].第三军医大学学报,2011,33(01):28. Hong Siqi,Bi Yang,Guo Zhenhua,et al.Construction of recombinant adenovirus with siANGPTL4 gene and its inhibitive effect on MG63 cell proliferation[J].J Third Mil Med Univ,2011,33(18):28.
